MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy - Wikidata - awgldk - TriplyDB

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

http://www.wikidata.org/entity/Q28259779

about

Analysis of miRNA and mRNA expression profiles highlights alterations in ionizing radiation response of human lymphocytes under modeled microgravity Investigation of the interaction between the MIR-503 and CD40 genes in irradiated U937 cells Molecular biology of lung cancer: clinical implications MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression Cloning, characterization and expression analysis of porcine microRNAs Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness MicroRNAs in breast cancer initiation and progression SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer Can microRNAs improve the management of lung cancer patients? A clinician's perspective Regulating miRNA by natural agents as a new strategy for cancer treatment A 3'-UTR KRAS-variant is associated with cisplatin resistance in patients with recurrent and/or metastatic head and neck squamous cell carcinoma MicroRNAs, DNA Damage Response, and Cancer Treatment MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential A functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiation Let-7 microRNA inhibits the proliferation of human glioblastoma cells Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes Therapeutic use of microRNAs in lung cancer miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 Assessment of biodosimetry methods for a mass-casualty radiological incident: medical response and management considerations.The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma Ionizing radiation-induced oxidative stress alters miRNA expression.LIN28B confers radio-resistance through the posttranscriptional control of KRAS.MicroRNA-218 enhances the radiosensitivity of human cervical cancer via promoting radiation induced apoptosis.Integrating microRNA and mRNA expression profiles in response to radiation-induced injury in rat lung.The potential clinical applications and prospects of microRNAs in lung cancer Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation.Lung cancer: a modified epigenome.MicroRNA expression after ionizing radiation in human endothelial cells.MicroRNA-26b represses colon cancer cell proliferation by inhibiting lymphoid enhancer factor 1 expression.microRNAs and lung cancer: tumors and 22-mers.The nuclear export receptor XPO-1 supports primary miRNA processing in C. elegans and Drosophila Mir-34a is upregulated during liver regeneration in rats and is associated with the suppression of hepatocyte proliferation.Coordinated regulation of ATF2 by miR-26b in γ-irradiated lung cancer cells.The cytotoxic ribonuclease onconase targets RNA interference (siRNA).Cellular stress induced alterations in microRNA let-7a and let-7b expression are dependent on p53 A let-7 microRNA-binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy.Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells.

P2860

Q21134789-1EECD78F-2E01-4E1F-8A8D-5BD6623E921B Q21203115-03E2D2C4-013E-403D-A836-45D19D4F6B4A Q24610335-C19DE635-764E-487F-AA9A-D7E5810F5723 Q24615514-9FFE2F96-895C-4BC7-B51C-F4F202A7C0C4 Q24651039-1F4A377D-284C-4A5D-90DB-1BFCC24E01D3 Q24655144-C44CB6C7-AFFB-4FF2-A02B-1266E91527E9 Q26782613-4CB38786-F0BB-4673-9577-D3FF30F4ACD5 Q26822776-F3589219-F8AC-4F85-B2C8-27618F08111D Q26823360-2CBE4977-3B07-4693-BCDF-4F5EF18D203F Q26829794-F976A8AE-2CEB-4168-BD0B-FB1EB35028AD Q26999304-1806E679-9399-40D8-9FCD-6838F2E90DE8 Q27026972-B07E1D01-F7A4-4201-BAE7-090BDBA5A596 Q27853046-CC56C527-2F09-4AB2-BF39-653D4FF4CDC8 Q28067062-138E3F9B-37FD-4C5B-983C-71834B1EA56C Q28081081-35ACDD82-D098-4DCA-907C-952C17C6738D Q28260029-7958B253-3729-41EF-AE1A-A719CE693684 Q28287254-AEC1065B-FA02-451E-9628-D98836696D94 Q28287476-A335E4BA-5BE0-4397-B85E-F20F274C73AE Q28289485-D1AED813-167F-432F-8FC8-7D99902EBA1C Q28395179-1F02C6CE-526A-4192-B333-DA7363F85A9F Q28606716-8C46C539-7781-49D2-9F9E-BD98051DA98B Q30219792-07386EDD-0164-4CC1-BDF2-9D97B960E66D Q33436471-24180B49-397D-40FC-9880-3A268E2CE98E Q33487162-EFBFCC17-313D-491E-B2E5-D323DFD508C5 Q33575786-949CA1F0-1584-440A-BCAA-C6BC9B64F92C Q33628432-290B5580-EF56-47FC-B831-0D05FD397A54 Q33708027-4FE03D35-BE4E-4873-88DB-2E7E69A331B6 Q33734765-5682DE4B-7230-46FC-B3B4-B853554EF0BF Q33751085-674A186D-AE47-4FED-A79E-C31CA969C0B0 Q33781123-58AE021C-4677-47B4-BCEC-D31E57AAD139 Q33809260-EA46D603-7897-40CC-8150-3985D5F4C6F3 Q33875645-58A5A471-1560-4393-98C1-89F1C8115722 Q33910328-D3859829-7864-4B50-920B-ADBB625FFFA1 Q33914384-45BFA484-4D4F-451F-B513-6029CFE23F3C Q33927250-B81BD5F7-30C1-414E-A146-68753AA56ACE Q34013747-197A5FB3-5E9C-4654-943A-36D243F5434E Q34014208-C818E43B-EAE1-4EE5-9494-1E9080A45094 Q34055428-52A7B665-0B75-4B29-AD00-C36807CF1F16 Q34138308-56956D55-4C0F-4498-829B-AD5BDCDBB27A Q34145858-6BC32E25-D7E2-48DD-A6AA-7F76A4675D48

P2860

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

http://www.wikidata.org/entity/Q28259779

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@ast

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@en

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@nl

type

label

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@ast

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@en

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@nl

prefLabel

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@ast

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@en

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@nl

P1433

Q28259779-010D2424-13E0-4C76-A16C-94EBEC6D8EA6

P1476

Q28259779-21A9D180-B1D6-4804-BD2C-610CE5A67C8F

P2093

Q28259779-35CE3EA1-6404-498C-8D00-71A2A5D9493E

Q28259779-6C6C1127-47F9-46BC-9FE6-31E85391ECF9

Q28259779-71E71F2B-A5BA-41FE-85E4-BDDEC6EFC16A

Q28259779-BB2834EC-B6DC-4C1F-A91B-9E1F1AACFC0B

Q28259779-E06F0CF6-4A1A-42BF-BB27-B0B4498FD4F4

P2860

Q28259779-073E68D5-DA6B-4BCF-998E-3EB5A016185C

Q28259779-07911F46-122E-493A-9B32-2A5E30646C04

Q28259779-0C14C9B4-3BFE-4CA7-B49C-A9A438AFADF4

Q28259779-23C050CD-1807-495E-B844-151408F79DDE

Q28259779-281A7059-4629-4F57-9F0F-33253B807000

Q28259779-2A42A5EC-7EE6-4A49-A57A-808952BBB33A

Q28259779-35114431-FAF3-476D-A087-F36526FA00FC

Q28259779-4C19E107-4C02-4B01-8469-013888F160E5

Q28259779-5229C477-8670-4CBE-9A68-EE0B98340C20

Q28259779-69183AF8-234F-43D4-A214-8B9C652CD029

P304

Q28259779-6AF2A554-0162-471F-898F-78F65D7DEED2

P31

Q28259779-88F17BD4-096D-4E94-A01F-EE6E68F716D5

P3181

Q28259779-7D137A2F-2CC0-48FB-8FFA-8D921A1278F9

P356

Q28259779-FE64CA1F-67E5-4CAA-A58F-59423F64857F

P407

Q28259779-A3DDE468-D583-44B1-AB43-6166AE763199

P433

Q28259779-6E3BA4DD-8070-464E-962D-D693E9442594

P478

Q28259779-B5099B74-C9C9-483A-A5F5-87EDDF1ACBEC

P50

Q28259779-2602F844-AE26-4F15-BA5A-17E9D4FA8B85

Q28259779-B88373B2-0265-42DD-81AC-7BBF0409B1AD

Q28259779-F754080A-4293-4B5B-A58C-7C58CB4BA5AA

P577

Q28259779-28F91C33-A1EA-49D8-80C0-E581D6AC8764

P5875

Q28259779-7FB102E6-17DB-4454-9F06-8A3197325D8D

P698

Q28259779-4EAB96B6-3B37-4787-9FDF-98652AFDEFE6

P921

Q28259779-85317790-1507-4DAC-9102-754F3E570A45

Q28259779-A24B4EED-AEB9-4013-8BBB-79037A8F581F

P932

Q28259779-5E3E2A23-1EF9-4163-8FB1-6A6443CAE4E0

P3181

P356

0008-5472.CAN-07-2858

P1433

Cancer Research

P1476

MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy

@en

P2093

Imran Babar

http://www.w3.org/2001/XMLSchema#string

Michelle Boehm

http://www.w3.org/2001/XMLSchema#string

Phong Trang

http://www.w3.org/2001/XMLSchema#string

Sarah Roush

http://www.w3.org/2001/XMLSchema#string

Sunitha M Nallur

http://www.w3.org/2001/XMLSchema#string

P2860

Post-embryonic expression of C. elegans microRNAs belonging to the lin-4 and let-7 families in the hypodermis and the reproductive system

Extensive post-transcriptional regulation of microRNAs and its implications for cancer

Prediction of mammalian microRNA targets

RAS is regulated by the let-7 microRNA family

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Oncomirs - microRNAs with a role in cancer

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

Identification of tissue-specific microRNAs from mouse

An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

P304

11111-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3277650

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-07-2858

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

67

http://www.w3.org/2001/XMLSchema#string

P50

Joanne B. Weidhaas

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5792602

http://www.w3.org/2001/XMLSchema#string

P698

18056433

http://www.w3.org/2001/XMLSchema#string

P921

P932

6070379

http://www.w3.org/2001/XMLSchema#string